They may soon be eligible for compounding if reclassified to Category 1
A 2019 network meta-analysis of 233 trials (n = 147,710) reported elevated risks of dizziness (odds ratios [ORs] 1.92, 1.57, 1.40) and headache (ORs 1.34, 1.41, 1.18) with GLP-1 RAs versus insulin, thiazolidinediones, and placebo 40
Models of gastric ulcers and intestinal inflammation, assessment of the integrity of the mucosa and endothelium historically the first area of research on the molecule, consistent with its gastric origin
If your diagnosis was made with just a quick prod and poke, then you havent been properly assessed
We do our best to answer all questions and thought it would be good to post the questions and answers to help others